BlackRock Advisors’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$2.02M Buy
10,972
+6,393
+140% +$1.18M ﹤0.01% 1453
2016
Q3
$1.18M Sell
4,579
-32,924
-88% -$8.48M ﹤0.01% 1688
2016
Q2
$8.01M Sell
37,503
-118,053
-76% -$25.2M 0.01% 897
2016
Q1
$32.1M Sell
155,556
-589
-0.4% -$121K 0.03% 404
2015
Q4
$39.5M Buy
156,145
+3,006
+2% +$760K 0.04% 360
2015
Q3
$25.2M Buy
153,139
+65,790
+75% +$10.8M 0.03% 459
2015
Q2
$16.4M Buy
87,349
+81,932
+1,512% +$15.4M 0.02% 589
2015
Q1
$894K Buy
5,417
+796
+17% +$131K ﹤0.01% 1605
2014
Q4
$1.07M Sell
4,621
-213
-4% -$49.5K ﹤0.01% 1422
2014
Q3
$875K Sell
4,834
-92
-2% -$16.7K ﹤0.01% 1491
2014
Q2
$947K Sell
4,926
-8,726
-64% -$1.68M ﹤0.01% 1505
2014
Q1
$2.48M Buy
13,652
+8,652
+173% +$1.57M ﹤0.01% 1109
2013
Q4
$851K Buy
5,000
+364
+8% +$62K ﹤0.01% 1600
2013
Q3
$726K Buy
4,636
+11
+0.2% +$1.72K ﹤0.01% 1624
2013
Q2
$801K Buy
+4,625
New +$801K ﹤0.01% 1494